NT-proBNP is used as a biomarker to predict both short- and long-term mortality in patients with the acute coronary syndrome (ACS), and it is closely linked to the levels of myocardial ischemia and cardiac function in ACS patients [2]. This evidence concerns the gene NPPB and acute coronary syndrome.